MedPath

Disease Management for Coronary Artery Patients

Not Applicable
Completed
Conditions
Patient Empowerment
Coronary Artery Disease
Registration Number
NCT04556006
Lead Sponsor
Kilis 7 Aralik University
Brief Summary

This randomized controlled trial was conducted with 58 patients hospitalized in the cardiology clinic of a state hospital. Personal Information Form, Anthropometric measurements, Framingham risk score, and compliance questionnaire (CQ) were used to collect the data.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • aged 18 and over,
  • diagnosed with coronary artery disease for at least 2 months,
  • no hearing and vision problem,
  • no perception and expression deficiency,
  • not diagnosed with any psychiatric disease,
  • living in Kilis province,
  • voluntary to participate in the study.
Exclusion Criteria
  • aged 18 under,
  • diagnosed without coronary artery disease for at least 2 months,
  • hearing and vision problem,
  • perception and expression deficiency,
  • diagnosed with any psychiatric disease,
  • no living in Kilis province,
  • no voluntary to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Compliance Questionnaire Scores of the ParticipantsInitially-12 weeks

Compliance Questionnaire is a form allowing to investigate 11 different areas such as the use of medication causing maladaptation in disease management in individuals with chronic illnesses, diet, weight loss, limiting physical activity, exercise, coping with stress, alcohol use, smoking, sexual activity problems, caffeine intake and working/job life. In the form allowing Likert-type evaluation, the participant is expected to select one of the options 0 (never), 1 (very rarely), 2 (sometimes), 3 (most of the time) or 4 (always) while expressing his/her compliance level for each adaptation area. The scores corresponding to the given expression are summed and Compliance Questionnaire score for each participant is determined. The score range that can be obtained for each subscale is 0-4. The Compliance Questionnaire total scores is between 0-44. High scores mean a better as it an increase in the compliance level to the disease.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kilis 7 Aralık University

🇹🇷

Kilis, Turkey

Kilis 7 Aralık University
🇹🇷Kilis, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.